Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06450028 · ClinicalTrials.gov registry record · Phase 4
Lidocaine Versus Bupivacaine in Orthognathic Surgery
A Phase 4 study, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
NCT06450028 is a Phase 4 study that has completed, run by Boston Children's Hospital. The registered enrollment target is 60 participants.
The verdict
NCT06450028, a Phase 4 study, has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
Study Summary
In this research study, we want to learn more about the impact of two different local anesthetics (bupivacaine and lidocaine) on patient experience following orthognathic (jaw) surgery. Both anesthetics are within the standard of care for dental and orthognathic procedures, but can vary in how quickly they take action and how long they last. This study will provide us with a greater understanding of how anesthetic choice affect patient outcomes, and how we can strive to make these outcomes as favorable as possible.
Interventions
- DRUG 10 cc of 0.25% bupivacaine hydrochloride with 1:200,000 epinephrine
- DRUG 6.8 cc of 2% lidocaine hydrochloride with 1:100,000 epinephrine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2024-07-26 |
| Est. Completion | 2025-11-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06450028
The ClinicalTrials.gov registry entry for NCT06450028 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 10 cc of 0.25% bupivacaine hydrochloride with 1:200,000 epinephrine is the first listed.
NCT06450028 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06450028 about?
NCT06450028 is a clinical study titled "Lidocaine Versus Bupivacaine in Orthognathic Surgery". In this research study, we want to learn more about the impact of two different local anesthetics (bupivacaine and lidocaine) on patient experience following orthognathic (jaw) surgery. Both anesthetics are within the standard of care for dental and orthognathic procedures, but can vary in how quick...
What is the current status of trial NCT06450028?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2024-07-26. Estimated completion is 2025-11-30.
What interventions are being tested in trial NCT06450028?
The interventions under investigation include: 10 cc of 0.25% bupivacaine hydrochloride with 1:200,000 epinephrine (DRUG), 6.8 cc of 2% lidocaine hydrochloride with 1:100,000 epinephrine (DRUG).
Who is sponsoring clinical trial NCT06450028?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.